Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:02 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Sio Capital Management, LLC | 0 0.000% |
-233,112 (Position Closed) |
Filing History |
| 2022-02-10 4:01 pm Sale |
2021-12-31 | 13G | Curis, Inc. CRIS |
Sio Capital Management, LLC | 193,332 4.220% |
-44,490 (-18.71%) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Sio Capital Management, LLC | 233,112 8.690% |
233,112 (New Position) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Curis, Inc. CRIS |
Sio Capital Management, LLC | 237,822 5.780% |
237,822 (New Position) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Sio Capital Management, LLC | 188,661 1.230% |
188,661 (New Position) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Sio Capital Management, LLC | 8,286 8.350% |
8,286 (New Position) |
Filing History |